SCHEMBL4419929

SCHEMBL4419929

Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1-c1cc(C(=O)NCCc2ccncc2)on1

nearest known ligand 0.58

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 14/20 0.58
RAF1 P04049 6/20 0.54
BRAF P15056 6/20 0.54
MAPK13 O15264 1/20 0.46
MAPK12 P53778 1/20 0.46
MAPK11 Q15759 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551704 0.90 MAPK14 (0.57) MAPK14RAF1BRAF
SCHEMBL5593544 0.89 RAF1 (0.59) MAPK14RAF1BRAF
SCHEMBL4410023 0.88 RAF1 (0.55) MAPK14RAF1BRAF
SCHEMBL4565439 0.87 RAF1 (0.56) MAPK14RAF1BRAF
SCHEMBL4552283 0.86 RAF1 (0.56) MAPK14RAF1BRAF
SCHEMBL4565118 0.86 RAF1 (0.56) MAPK14RAF1BRAF
SCHEMBL5593026 0.86 RAF1 (0.61) MAPK14RAF1BRAF
SCHEMBL4541475 0.86 RAF1 (0.56) MAPK14RAF1BRAF
SCHEMBL5603999 0.85 MAPK14 (0.53) MAPK14RAF1BRAFMAPK13MAPK12
SCHEMBL4551205 0.85 RAF1 (0.62) MAPK14RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed